Valentina Giorgio

Summary

Country: Italy

Publications

  1. pmc Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets
    Valentina Giorgio
    Hepato metabolic Unit, Bambino Gesu Children Hospital, Rome, Italy
    BMC Pediatr 13:40. 2013
  2. doi request reprint Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk
    Luca Miele
    Institute of Internal Medicine, Policlinico Gemelli Hospital, Catholic University of Sacred Heart of Rome, Rome, Italy
    Curr Cardiol Rep 17:120. 2015
  3. doi request reprint Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity
    Valentina Giorgio
    Hepato Metabolic Disease Unit, Bambino Gesu Children Hospital, Rome, Italy
    Dig Liver Dis 46:556-60. 2014
  4. pmc Digestive Enzyme Supplementation in Gastrointestinal Diseases
    Gianluca Ianiro
    Department of Medical Sciences, Division of Internal Medicine, Gastroenterology and Liver Unit, Catholic University, School of Medicine and Surgery, A Gemelli Hospital Rome, Italy, Largo A Gemelli 8, IT 00168 Rome, Italy
    Curr Drug Metab 17:187-93. 2016
  5. doi request reprint Vitamin D levels and liver histological alterations in children with nonalcoholic fatty liver disease
    Valerio Nobili
    Hepato Metabolic Disease Unit, Bambino Gesu Children s Hospital IRCCS, Rome, Italy
    Eur J Endocrinol 170:547-53. 2014

Collaborators

Detail Information

Publications5

  1. pmc Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets
    Valentina Giorgio
    Hepato metabolic Unit, Bambino Gesu Children Hospital, Rome, Italy
    BMC Pediatr 13:40. 2013
    ..This review provides an overview of current and new clinical-histological concepts of pediatric NAFLD, going through possible implications into patho-physiolocical and therapeutic perspectives...
  2. doi request reprint Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk
    Luca Miele
    Institute of Internal Medicine, Policlinico Gemelli Hospital, Catholic University of Sacred Heart of Rome, Rome, Italy
    Curr Cardiol Rep 17:120. 2015
    ..In this paper, we have reviewed the impact of gut microbiota on metabolic disorders and cardiovascular disease risk, focusing on the newest findings in this field. ..
  3. doi request reprint Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity
    Valentina Giorgio
    Hepato Metabolic Disease Unit, Bambino Gesu Children Hospital, Rome, Italy
    Dig Liver Dis 46:556-60. 2014
    ..Increased intestinal permeability seems to play a major role in non-alcoholic liver disease development and progression...
  4. pmc Digestive Enzyme Supplementation in Gastrointestinal Diseases
    Gianluca Ianiro
    Department of Medical Sciences, Division of Internal Medicine, Gastroenterology and Liver Unit, Catholic University, School of Medicine and Surgery, A Gemelli Hospital Rome, Italy, Largo A Gemelli 8, IT 00168 Rome, Italy
    Curr Drug Metab 17:187-93. 2016
    ..To date, several formulations of digestive enzymes are available on the market, being different each other in terms of enzyme type, source and origin, and dosage...
  5. doi request reprint Vitamin D levels and liver histological alterations in children with nonalcoholic fatty liver disease
    Valerio Nobili
    Hepato Metabolic Disease Unit, Bambino Gesu Children s Hospital IRCCS, Rome, Italy
    Eur J Endocrinol 170:547-53. 2014
    ..To investigate the association between plasma vitamin D (VD) levels and histological liver damage in children with nonalcoholic fatty liver disease (NAFLD)...